Anbio Biotechnology Class A Ordinary Shares
NNNN | NASDAQ
$5.68
+$0.43 (+8.19%)
At close: Sep 21, 2026, 4:00 PM ET
$5.68
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $230.43M
Enterprise Value $237.4M
Beta 5.13
Average Volume 78.94K
Shares Outstanding (Diluted) 43.89M
Shares Change YoY 3.78%
Institutional Ownership 0.11%
Exchange NASDAQ
ISIN KYG0367B1059
Price Performance
Price Change 1M -16.1%
Price Change 3M -63.8%
Price Change 6M -76.1%
Price Change YTD -80.7%
Price Change 1Y -85.0%
Price Change 3Y -1.6%
Price Change 5Y -1.6%
1M CAGR (ann.) -46.1%
1Y CAGR (ann.) -87.8%
5Y CAGR (ann.) N/A
All-Time CAGR -5.8%
Valuation
PE Ratio 35.50
Forward PE N/A
PEG Ratio 0.27
Forward PEG 0.27
PS Ratio 25.58
Forward PS N/A
PB Ratio 8.27
P/FCF Ratio 110.70
P/Adj. FCF Ratio 110.70
P/OCF Ratio N/A
EV/Sales 24.36
EV/EBIT 34.17
EV/EBITDA 34.17
EV/FCF 105.42
Earnings Yield 2.8%
FCF Yield 0.9%
Adj. FCF Yield 0.9%
Financial Health
Net Cash $11.9M
Total Debt $0
Cash & Short-Term Investments $11.9M
Total Assets $30.24M
Current Ratio 344.31
Quick Ratio 344.31
Debt / Equity Ratio 0.00
Debt / EBITDA 0.00
Debt / FCF 0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score 1,577.41
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 86.1%
Operating Profit Margin 66.5%
EBITDA Margin 55.0%
Net Profit Margin 72.1%
FCF Margin 23.1%
Adj. FCF Margin 23.1%
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets 28.1%
Return on Equity 27.5%
Return on Invested Capital 25.5%
Return on Capital Employed 25.5%
Return on Tangible Assets 28.1%
Historical Growth (CAGR)
Revenue CAGR 3Y -28.4%
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y 32.0%
EPS CAGR 5Y N/A
EPS CAGR 10Y N/A
FCF CAGR 3Y -304.7%
FCF CAGR 5Y N/A
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number $1.58
Graham Upside -72.2%
Lynch Fair Value N/A
Lynch Upside N/A
Price Target N/A
Price Target Upside N/A
Cash Flow
Operating Cash Flow $2.25M
Free Cash Flow $2.25M
Adj. Free Cash Flow $2.25M
FCF Per Share $0
OCF Per Share $0
OCF/S Ratio 0.0%
Income Statement
Revenue $9.74M
Gross Profit $8.48M
Operating Income $6.48M
EBITDA $6.95M
Net Income $7.19M
EPS (Diluted) $0.16
Revenue / Employee $360.92K
Profit / Employee $266.18K
Employees 27
Add to Watchlist
Select watchlists to add or remove NNNN